BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33819783)

  • 1. Serum-derived exosomes function as tumor antigens in patients with advanced hepatocellular carcinoma.
    Shi S; Wang L; Wang C; Xu J; Niu Z
    Mol Immunol; 2021 Jun; 134():210-217. PubMed ID: 33819783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells.
    Li J; Lin W; Huang T; Chen M; Lin Q
    Exp Cell Res; 2024 Jun; 439(1):114073. PubMed ID: 38704079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
    Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
    Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.
    Han Y; Wu Y; Yang C; Huang J; Guo Y; Liu L; Chen P; Wu D; Liu J; Li J; Zhou X; Hou J
    J Transl Med; 2017 Mar; 15(1):64. PubMed ID: 28330473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunity mechanism of exosomes derived from dendritic cells].
    Ren YN; Fan HH; Nie XX; Gao L; Yang J; Liu Y; Gao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):650-4. PubMed ID: 18549647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
    Zuo B; Qi H; Lu Z; Chen L; Sun B; Yang R; Zhang Y; Liu Z; Gao X; You A; Wu L; Jing R; Zhou Q; Yin H
    Nat Commun; 2020 Apr; 11(1):1790. PubMed ID: 32286296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].
    Wong YQ; Qiu SJ; Tang ZY; Ye SL; Liu YK; Fan J; Sun RX; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):339-42. PubMed ID: 15918966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A preliminary study of the killing function in vitro by T lymphocytes activated by dendritic cells loaded with exosomes secreted by hepatic cancer cell lines with high or low metastatic potentials].
    Wang KF; Ye SL; Song LJ; Cui JF; Weng YQ; Liang CM; Sun RX; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):658-62. PubMed ID: 17903366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.
    Friedl J; Stift A; Paolini P; Roth E; Steger GG; Mader R; Jakesz R; Gnant MF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):477-86. PubMed ID: 11155819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of tumor antigen specific CTL induced by dendritic cells on a model of human hepatocellular carcinoma in nude mice (LCI-D20)].
    Chen GL; Hu HD; Ma YJ; Li YG; Xue Q; Chen M; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):431-4. PubMed ID: 16792867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
    Su H; Li B; Zheng L; Wang H; Zhang L
    Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY; Wang L; Lu MD; Li BJ; Huang JF
    Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.